Gregory Fraser
Stock Analyst at Truist Securities
(2.72)
# 1,841
Out of 5,128 analysts
39
Total ratings
57.14%
Success rate
17.25%
Average return
Main Sectors:
Stocks Rated by Gregory Fraser
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ANIP ANI Pharmaceuticals | Maintains: Hold | $77 → $90 | $79.47 | +13.25% | 11 | Oct 9, 2025 | |
| JAZZ Jazz Pharmaceuticals | Maintains: Buy | $200 → $205 | $169.37 | +21.04% | 2 | Aug 28, 2025 | |
| BHC Bausch Health Companies | Maintains: Hold | $8 → $7 | $7.90 | -11.39% | 2 | Jul 25, 2024 | |
| XAIR Beyond Air | Maintains: Buy | $200 → $160 | $0.83 | +19,200.36% | 6 | Apr 30, 2024 | |
| BTMD biote | Maintains: Buy | $10 → $9 | $2.45 | +267.35% | 2 | Jan 18, 2024 | |
| AMRX Amneal Pharmaceuticals | Maintains: Buy | $6 → $7 | $13.26 | -47.21% | 4 | Nov 8, 2023 | |
| CORT Corcept Therapeutics | Maintains: Hold | $26 → $29 | $37.00 | -21.62% | 5 | Aug 3, 2023 | |
| NVCR NovoCure | Reiterates: Buy | $95 | $14.41 | +559.26% | 3 | Jun 6, 2023 | |
| EOLS Evolus | Maintains: Buy | $14 → $18 | $5.66 | +218.02% | 2 | May 26, 2023 | |
| ARQT Arcutis Biotherapeutics | Maintains: Buy | $45 → $40 | $29.58 | +35.23% | 2 | May 26, 2023 |
ANI Pharmaceuticals
Oct 9, 2025
Maintains: Hold
Price Target: $77 → $90
Current: $79.47
Upside: +13.25%
Jazz Pharmaceuticals
Aug 28, 2025
Maintains: Buy
Price Target: $200 → $205
Current: $169.37
Upside: +21.04%
Bausch Health Companies
Jul 25, 2024
Maintains: Hold
Price Target: $8 → $7
Current: $7.90
Upside: -11.39%
Beyond Air
Apr 30, 2024
Maintains: Buy
Price Target: $200 → $160
Current: $0.83
Upside: +19,200.36%
biote
Jan 18, 2024
Maintains: Buy
Price Target: $10 → $9
Current: $2.45
Upside: +267.35%
Amneal Pharmaceuticals
Nov 8, 2023
Maintains: Buy
Price Target: $6 → $7
Current: $13.26
Upside: -47.21%
Corcept Therapeutics
Aug 3, 2023
Maintains: Hold
Price Target: $26 → $29
Current: $37.00
Upside: -21.62%
NovoCure
Jun 6, 2023
Reiterates: Buy
Price Target: $95
Current: $14.41
Upside: +559.26%
Evolus
May 26, 2023
Maintains: Buy
Price Target: $14 → $18
Current: $5.66
Upside: +218.02%
Arcutis Biotherapeutics
May 26, 2023
Maintains: Buy
Price Target: $45 → $40
Current: $29.58
Upside: +35.23%